NEW

Top 25 Biotech Companies of 2024

Article originally published on GEN The biotechnology industry achieved many firsts this past year, from the first approved drug that can slow the rates of cognitive and functional decline in adults with Alzheimer’s disease, to the first CRISPR-based gene editing...

Bringing Legacy Combination Products into Compliance with 21 CFR Part 4

At the CASSS CMC Strategy Forum in July of this year, BioTechLogic’s Tracy TreDenick, Head of Regulatory and Quality and Senior Consultant, delivered a presentation discussing how to bring legacy combination products into compliance with 21 CFR Part 4. BioTechLogic has a wealth of experience in this area and have successfully helped a number of combination product manufacturers with this very issue. We hope you find the presentation deck to be informative and let us know if we can help you. Also, stay tuned for more on this topic.

Previous

Next